
E2F3 - Wikipedia
The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor ...
E2F cell cycle pathway score as a predictive biomarker of …
The E2F pathway score was calculated by Gene Set Variant Analysis (GSVA). Results: Tumors with high E2F pathway score enriched cell proliferation and cell cycle pathway related gene sets (G2M, MYC v1, and v2, MITOTIC, MTORC1, PI3K AKT MTOR, and DNA repair; FDR < 0.001). The high E2F pathway score was significantly associated with TNBC and HER2 ...
Gene expression changes in response to E2F1 activation - PMC
Hypophosphorylated RB binds E2F and thereby down-regulates E2F activity, suggesting a model in which RB restricts cell cycle progression by restraining E2F (6–8). In fact, the interaction of RB with E2F correlates with the capacity of RB to arrest cell growth in the G1 phase .
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F …
2 days ago · AbstractPurpose:. Advanced prostate cancer is invariably fatal, with the androgen receptor (AR) being a major therapeutic target. AR signaling inhibitors have improved overall survival for men with advanced prostate cancer, but treatment resistance is inevitable and includes reactivation of AR signaling. Novel therapeutic approaches targeting these …
Complex Cartography: Regulation of E2F Transcription ... - Cell Press
The E2F family of transcriptional regulators sits at the center of cell cycle gene expression and plays vital roles in normal and cancer cell cycles. Whereas control of E2Fs by the retinoblastoma family of proteins is well established, much less is known about their regulation by ubiquitin pathways. Recent studies placed the Skp1-Cul1-F-box-protein (SCF) family of E3 ubiquitin …
Understanding Proto-Oncogenes and Tumor Suppressors in …
4 days ago · If E2F were to have a gain of function there wouldn’t be a need for RB there would be constant activity. 2. List two tumor suppressor genes. For each, describe what might happen with a loss-of-function mutation. Ans: p21 and RB. IF p21 were to have a loss of function CDK2 wouldn’t be proofread and it would be unchecked phosphorylation.
Chemical Biology & Drug Design - Wiley Online Library
Feb 11, 2025 · The expression of mediator complex subunit 7 (MED7) and E2F transcription factor 1 (E2F1) was analyzed by quantitative real-time polymerase chain reaction or Western blotting assay. Cell proliferation was assessed by cell colony formation assay and 5-ethynyl-2′-deoxyuridine assay. Cell migration was analyzed by transwell assay and wound ...
Dissection of Tumoral Niches Using Spatial ... - ScienceDirect
6 days ago · Tumor-E2F: This niche is enriched in the E2F Targets pathway, which is associated with cell cycle 391 regulation, proliferation, differentiation and stress responses (Table 5) 72. 392 2. Tumor-Unidentified: The second niche, while not presenting any pathway enrichment, contained 393 both Tumor and Neutrophil cells (Figure 8d), indicating ...
E2F7, a novel target, is up-regulated by p53 and mediates DNA …
E2F7 was the only E2F analyzed in this study found to be consistently up-regulated in response to either doxorubicin or etoposide treatment (Fig. 1B–E). E2F7 is a p53 target. In order to investigate the p53 dependence of the up-regulation of E2F7, p53 levels were increased in the absence of DNA damage by treating U2OS cells with increasing ...
E2F, can also regulate cell cycle progression in CMs [55]. Proteins aecting cell cycle regulation during myocardial regeneration are shown in Table 1. de‑dierentiation and re‑dierentiation Another possible mechanism is the dedierentiation and …
- Some results have been removed